OncClubAll Oncology NewsPipeline Report
InsightsMedical World NewsOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsThe Talk
Conference CoverageConference Listing
Giants of Cancer CarePER EventsScientific InterchangesState of the Science Summit / IPCWebinars
Partners
Oncology Live®Oncology FellowsSupplements And Featured PublicationsAll Publications
CME/CE
Interactive ToolsLearning ModulesPresentationsSponsored
Biomarker Consortium
Print SubscriptioneNewsletter
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
Spotlight -
  • 2024 nominations are open for Giants of Cancer Care®
  • In-person and virtual events just for HCPs
  • REGISTER TODAY to explore data on a novel second-generation BTK inhibitor for adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
  • Share your views with OncChats
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
    • Partners
    • CME/CE
    • Biomarker Consortium
Advertisement

Paul Bunn, MD, University of Colorado Cancer Center

home / authors / paul-bunn,-md,-university-of-colorado-cancer-center

Articles

Advertisement

Reducing the Impact of Chemotherapy-Induced Myelosuppression

Reducing the Impact of Chemotherapy-Induced Myelosuppression

September 16th 2020

Read More


CDK4/6 Inhibitors & Myelopreservation in Other Cancers

CDK4/6 Inhibitors & Myelopreservation in Other Cancers

September 16th 2020

Read More


CDK4/6 Inhibitors for SCLC: Trials of Interest

CDK4/6 Inhibitors for SCLC: Trials of Interest

September 16th 2020

Read More


Chemotherapy-Induced Myelosuppression in SCLC: CDK4/6 Inhibition

Chemotherapy-Induced Myelosuppression in SCLC: CDK4/6 Inhibition

September 16th 2020

Read More


Analyses of CDK4/6 Inhibitors for Myelopreservation

Analyses of CDK4/6 Inhibitors for Myelopreservation

September 16th 2020

Read More


CDK4/6 Inhibitors and Myelopreservation

CDK4/6 Inhibitors and Myelopreservation

September 16th 2020

Read More

Advertisement

Chemotherapy-Induced Myelosuppression & COVID-19

Chemotherapy-Induced Myelosuppression & COVID-19

September 16th 2020

Read More


Management of Chemo-Induced Myelosuppression

Management of Chemo-Induced Myelosuppression

September 16th 2020

Read More


Chemotherapy Use & Chemotherapy-Induced Myelosuppression

Chemotherapy Use & Chemotherapy-Induced Myelosuppression

September 16th 2020

Read More


KRAS G12C Inhibition in Advanced NSCLC: MRTX849

KRAS G12C Inhibition in Advanced NSCLC: MRTX849

August 3rd 2020

Read More


KRAS G12C Inhibition in Advanced NSCLC: AMG 510

KRAS G12C Inhibition in Advanced NSCLC: AMG 510

August 3rd 2020

Read More


Development of KRAS G12C-Targeted Therapy in NSCLC

Development of KRAS G12C-Targeted Therapy in NSCLC

August 3rd 2020

Read More

Advertisement

Systemic Therapy for KRAS+ Advanced NSCLC

Systemic Therapy for KRAS+ Advanced NSCLC

August 3rd 2020

Read More


Counseling Patients With NSCLC When KRAS is Detected

Counseling Patients With NSCLC When KRAS is Detected

August 3rd 2020

Read More


Testing for KRAS Mutations in NSCLC

Testing for KRAS Mutations in NSCLC

August 3rd 2020

Read More


KRAS Mutations in Solid Tumors

KRAS Mutations in Solid Tumors

August 3rd 2020

Read More


Current Management of Oncogene-Driven NSCLC

Current Management of Oncogene-Driven NSCLC

August 3rd 2020

Read More

Latest Conference Coverage

Dr Ganesan on the Use of ctDNA Assays For MRD Detection in Cancer Care

Dr Habib on Developments in Palliative Care For Patients With Cancer

Dr Boland on the Emergence of KRAS G12C Inhibitors in mCRC

Dr In on the Increased Incidence of Gastric Cancer in Minority Patient Populations

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact